Syntaxin-binding protein 5 exocytosis regulation: Differential role in endothelial cells and platelets

Journal of Clinical Investigation

Volumn 124, Issue 10, 2014, Pages 4231-4233

  Lillicrap, David ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; SYNTAXIN BINDING PROTEIN 5; UNCLASSIFIED DRUG;

ENDOTHELIUM CELL; EXOCYTOSIS; HOMEOSTASIS; HUMAN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; THROMBOCYTE;

EID: 84907486976     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI77511     Document Type: Review

References (15)

1. Croce K, Libby P. Intertwining of thrombosis and inflammation in atherosclerosis. Curr Opin Hematol. 2007;14(1):55-61.
2. Mackman N. Triggers, targets and treatments for thrombosis. Nature. 2008;451(7181):914-918.
3. Jennings LK. Role of platelets in atherothrombosis. Am J Cardiol. 2009;103(3 suppl):4A-10A.
4. Otsuka F, et al. The importance of the endothelium in atherothrombosis and coronary stenting. Nat Rev Cardiol. 2012;9(8):439-453.
5. Flaumenhaft R. Molecular basis of platelet granule secretion. Arterioscler Thromb Vasc Biol. 2003;23(7):1152-1160.
6. Van Mourik JA, Romani De WT, Voorberg J. Biogenesis and exocytosis of Weibel-Palade bodies. Histochem Biol. 2002;117(2):113-122.
7. Ye S, et al. Platelet secretion and hemostasis require syntaxin-binding protein STXBP5. J Clin Invest. 2014;124(10):4517-4528.
8. Zhu Q, et al. Syntaxin-binding protein STXBP5 inhibits endothelial exocytosis and promotes platelet secretion. J Clin Invest. 2014;124(10):4503-4516.
9. Smith NL, et al. Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium. Circulation. 2010;121(12):1382-1392.
10. Van Loon JE, et al. Effect of genetic variations in syntaxin-binding protein-5 and syntaxin-2 on von Willebrand factor concentration and cardiovascular risk. Circ Cardiovasc Genet. 2010;3(6):507-512.
11. Antoni G, et al. Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels. BMC Med Genet. 2011;12(1):102.
12. Smith NL, et al. Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis. Blood. 2011;117(22):6007-6011.
13. Van Loon JE, et al. Effect of genetic variation in STXBP5 and STX2 on von Willebrand factor and bleeding phenotype in type 1 von Willebrand disease patients. PLoS One. 2012;7(7):e40624.
14. Fujita Y, et al. Tomosyn: a syntaxin-1-binding protein that forms a novel complex in the neurotransmitter release process. Neuron. 1998;20(5):905-915.
15. Zhang W, et al. Tomosyn is expressed in betacells and negatively regulates insulin exocytosis. Diabetes. 2006;55(3):574-581.